Bonyf NV (MLBON) - Net Assets

Latest as of September 2021: €433.97K EUR ≈ $507.35K USD

Based on the latest financial reports, Bonyf NV (MLBON) has net assets worth €433.97K EUR (≈ $507.35K USD) as of September 2021. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.68 Million ≈ $1.96 Million USD) and total liabilities (€1.25 Million ≈ $1.46 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of Bonyf NV for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€433.97K
% of Total Assets	25.82%
Annual Growth Rate	50.21%
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	539.79

Bonyf NV - Net Assets Trend (2019–2024)

This chart illustrates how Bonyf NV's net assets have evolved over time, based on quarterly financial data. Also explore Bonyf NV total assets for the complete picture of this company's asset base.

Annual Net Assets for Bonyf NV (2019–2024)

The table below shows the annual net assets of Bonyf NV from 2019 to 2024. For live valuation and market cap data, see MLBON market cap.

Year	Net Assets	Change
2024-12-31	€2.64 Million ≈ $3.09 Million	-1.36%
2023-12-31	€2.68 Million ≈ $3.13 Million	-28.04%
2022-12-31	€3.73 Million ≈ $4.36 Million	+1230.28%
2020-12-31	€280.06K ≈ $327.42K	-18.93%
2019-12-31	€345.47K ≈ $403.89K	--

Equity Component Analysis

This analysis shows how different components contribute to Bonyf NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 8015.1% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	€7.06 Million	267.10%
Other Components	€7.34K	0.28%
Total Equity	€2.64 Million	100.00%

Bonyf NV Competitors by Market Cap

The table below lists competitors of Bonyf NV ranked by their market capitalization.

Company	Market Cap
DGB Asia Bhd KLSE:0152	$2.90 Million
S&U plc LSE:SUS	$2.91 Million
Aberdeen International Inc. TO:AAB	$2.91 Million
Ximen Mining Corp V:XIM	$2.91 Million
LOBE SCIENCES LTD F:6YX0	$2.90 Million
Kumho Industrial Co Ltd KO:002995	$2.90 Million
Beeio Honey Ltd TA:BHNY	$2.90 Million
Capitan Investment Ltd V:CAI	$2.90 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bonyf NV's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,680,922 to 2,644,412, a change of -36,510 (-1.4%).
Net loss of 36,509 reduced equity.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€-36.51K	-1.38%
Other Changes	€-1.00	-0.0%
Total Change	€-	-1.36%

Book Value vs Market Value Analysis

This analysis compares Bonyf NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.94x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 7.19x to 0.94x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2019-12-31	€0.59	€4.22	x
2020-12-31	€0.48	€4.22	x
2022-12-31	€6.33	€4.22	x
2023-12-31	€4.55	€4.22	x
2024-12-31	€4.49	€4.22	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bonyf NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -1.38%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -12.97%
• Asset Turnover: 0.08x
• Equity Multiplier: 1.26x
Recent ROE (-1.38%) is above the historical average (-19.85%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2019	55.19%	5.96%	2.31x	4.01x	€156.13K
2020	-25.06%	-2.96%	1.72x	4.93x	€-98.18K
2022	-89.06%	-1196.14%	0.07x	1.12x	€-3.69 Million
2023	-38.97%	-337.68%	0.10x	1.15x	€-1.31 Million
2024	-1.38%	-12.97%	0.08x	1.26x	€-300.95K

Industry Comparison

This section compares Bonyf NV's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $5,592,045,138
Average return on equity (ROE) among peers: -7.62%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Bonyf NV (MLBON)	€433.97K	55.19%	2.87x	$2.90 Million
Crossject (ALCJ)	$-5.48 Million	0.00%	0.00x	$110.24 Million
I.Ceram SA (ALICR)	$1.24 Million	-26.37%	1.75x	$155.73K
Safe Orthopaedics SA (ALSAF)	$-1.28 Million	0.00%	0.00x	$135.92K
Spineway (ALSPW)	$4.62 Million	-36.05%	1.43x	$6.22 Million
Amplitude Surgical SAS (AMPLI)	$118.76 Million	-14.86%	1.08x	$299.85 Million
Sartorius Stedim Biotech SA (DIM)	$879.45 Million	18.32%	0.60x	$17.02 Billion
EssilorLuxottica S. A. (EL)	$38.15 Billion	5.64%	0.59x	$92.84 Billion

About Bonyf NV

PA:MLBON France Medical Instruments & Supplies

Market Cap

$2.90 Million

€2.48 Million EUR

Market Cap Rank

#29252 Global

#545 in France

Share Price

€4.22

Change (1 day)

+0.00%

52-Week Range

€3.96 - €17.40

All Time High

€17.80